Guardant Health, Inc. - stock earnings
GH Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -187.0 million USD | 155.1 million USD |
| 2023Q3 | -86.1 million USD | 143.0 million USD |
| 2023Q2 | -72.8 million USD | 137.2 million USD |
| 2023Q1 | -133.5 million USD | 128.7 million USD |
| 2022Q4 | -139.9 million USD | 126.9 million USD |
| 2022Q3 | -162.0 million USD | 117.4 million USD |
| 2022Q2 | -229.4 million USD | 109.1 million USD |
| 2022Q1 | -123.2 million USD | 96.1 million USD |
| 2021Q4 | -90.9 million USD | 108.1 million USD |
| 2021Q3 | -107.5 million USD | 94.8 million USD |
| 2021Q2 | -97.6 million USD | 92.1 million USD |
| 2021Q1 | -109.7 million USD | 78.7 million USD |
| 2020Q4 | -93.7 million USD | 78.3 million USD |
| 2020Q3 | -77.7 million USD | 74.6 million USD |
| 2020Q2 | -54.6 million USD | 66.3 million USD |
| 2020Q1 | -27.7 million USD | 67.5 million USD |
| 2019Q4 | -25.2 million USD | 62.9 million USD |
| 2019Q3 | -12.8 million USD | 60.8 million USD |
| 2019Q2 | -11.6 million USD | 54.0 million USD |
| 2019Q1 | -26.1 million USD | 36.7 million USD |
| 2018Q4 | -25.1 million USD | 32.9 million USD |
| 2018Q3 | -24.5 million USD | 21.7 million USD |
| 2018Q2 | -21.6 million USD | 19.4 million USD |
| 2018Q1 | -13.8 million USD | 16.7 million USD |
| 2017Q4 | -15.1 million USD | 20.0 million USD |
| 2017Q3 | -28.6 million USD | 11.1 million USD |
| 2017Q2 | ? USD | 10.2 million USD |
| 2017Q1 | ? USD | 8.5 million USD |
| 2016Q4 | -46.1 million USD | 25.2 million USD |
GH Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -479.4 million USD | 563.9 million USD |
| 2022 | -654.6 million USD | 449.5 million USD |
| 2021 | -384.8 million USD | 373.7 million USD |
| 2020 | -246.3 million USD | 286.7 million USD |
| 2019 | -67.9 million USD | 214.4 million USD |
| 2018 | -85.1 million USD | 90.6 million USD |
| 2017 | -83.2 million USD | 49.8 million USD |
| 2016 | -46.1 million USD | 25.2 million USD |
GH
Price: $18.88
52 week price:
Earnings Per Share: -4.28 USD
P/E Ratio: -5.56
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 409714
Market Capitalization: 2.2 billion